1 The modulatory eect of 5-hydroxytryptamine (5-HT) on the g-aminobutyric acid A (GABA A ) response was investigated in the neurones freshly dissociated from the rat sacral dorsal commissural nucleus (SDCN) using the nystatin perforated patch recording con®guration under the voltage-clamp conditions. 2 5-HT potentiated GABA-induced Cl 7 current (I GABA ) without aecting the reversal potential of I GABA and the apparent anity of GABA to its receptor. 3 a-Methyl-5-HT mimicked the potentiation eect of 5-HT on I GABA while ketanserine blocked it. 1-Oleoyl-2-acetyl-glycerol (OAG) potentiated I GABA , and the eect of 5-HT on I GABA was occluded by OAG pretreatment. In the presence of chelerythrine, 5-HT failed to potentiate I GABA , suggesting that protein kinase C (PKC) is involved in the pathway through which the activation of the 5-HT 2 receptor potentiates the I GABA . 4 The facilitatory eect of 5-HT on I GABA remained in the presence of BAPTA-AM. LiCl also had no eect on 5-HT-induced potentiation of I GABA . 5 H-89, genistein, okadaic acid and pervanadate all had no eects on 5-HT potentiation of I GABA . Pertussis toxin treatment for 6 ± 8 h did not block the facilitatory eect of 5-HT on I GABA . 6 The present results show that GABA A receptor in the rat SDCN could be modulated in situ by 5-HT, one of the major transmitters involved in the supraspinal control of nociception, and that the phosphorylation of GABA A receptor by PKC may be sucient to support such modulation. The results also strongly support the hypothesis that the cotransmission by 5-HT and GABA has an important role in the spinal cord.
Introduction 5-HT (5-hydroxytryptamine) is one of the major transmitters involved in the supraspinal control of nociception (for review, see Fields & Basbaum, 1994) . It is well known that the rat spinal dorsal horn is heavily innervated with 5-HT-like immunoreactive ®bres, and that 5-HT-containing neurones sending descending projections to the spinal dorsal horn are localized in the rostral ventromedial medulla (RVM) and caudal pons, including the nucleus raphe magnus, nucleus reticularis paragigantocellularis, and ventral portions of the nucleus rectilaris gigantocellularis (Jones & Light, 1990; Kwiat & Basbaum, 1992) . Axon terminals of descending 5-HT ®bres from the RVM to the spinal cord make axosomatic and axodendritic synapses with both spinothalamic projection neurones and local circuit neurones in the spinal dorsal horn of the monkey (Basbaum et al., 1986) and cat (Light & Kavookjian, 1985) . Direct contacts of 5-hydroxytryptaminergic axon terminals on nociceptive projection neurones in the caudal spinal trigeminal nucleus of the rat have also been demonstrated recently (Li et al., 1997) .
Activation of RVM neurones by electrical stimulation or glutamate microinjection depresses the activity of nociceptive neurones in the spinal dorsal horn, and produces behavioural antinociception (Basbaum et al., 1976; Jensen & Yaksh, 1989) . Several possible mechanisms have been suggested to lead to such depression: a direct postsynaptic action of 5-HT through an increase of K + conductance (Grudt et al., 1995) , a presynaptic inhibition of the primary aerent terminals by 5-HT (Hentall & Fields, 1983) , an inhibitory action on neuronal response to excitatory amino acids (Murase et al., 1990) , an increased inhibitory action through the activation of the local glycinergic interneurones (Grudt et al., 1995) or endogenous opiate-like substances (Yang et al., 1994) , and a 5-hydroxytryptaminergic enhancement of postsynaptic glycinergic transmission (Xu et al., 1996) .
It has been determined that g-aminobutyric acid (GABA) and 5-HT coexist in the neurones of medulla oblongata projecting to the spinal cord (Millhorn et al., 1987) . The extensive GABAergic innervation of spinal dorsal horn by ®bres descending from RVM has been demonstrated recently (Antal et al., 1996) . And recent immunohistochemical experiments have shown that the major GABA A receptor subtypes detected in the brain are also present in the spinal cord (Bohlhalter et al., 1996; Todd et al., 1996) . On the other hand, although the glycinergic mechanism for the inhibitory neurotransmission in the spinal cord has received much emphasis in the past, there is growing pharmacological and physiological evidence that a GABAergic mechanism also contributes to the inhibitory in¯uences on the spinal cord (McGowan & Hammond, 1993; Sorkin et al., 1993; Lin et al., 1994; Yoshimura & Nishi, 1995) . The above evidence suggests that 5-HT and GABA could be coreleased and act as cotransmitters in the spinal dorsal horn and that the functional cross-communication between 5-HT and GABA A receptors might be one of the modulatory processes of spinal nociception.
In this study, the eect of 5-HT on GABA A receptormediated response was investigated in the neurones freshly dissociated from rat sacral dorsal commissural nucleus (SDCN) using the nystatin perforated patch recording con®guration under voltage-clamp conditions. The SDCN is localized in the dorsal part of the central canal of the lower lumbar and sacral spinal cord of the rat and is known to be implicated in nociceptive transmission (Xu et al., 1996) . In particular, we characterized the role of protein kinase C (PKC) in the intracellular transduction pathway through which 5-HT induces the enhancement of GABA A receptor-mediated inhibitory response.
Methods

Preparation
The sacral dorsal commissural nucleus (SDCN) neurones were acutely dissociated as described elsewhere (Xu et al., 1996) . Brie¯y, two-week-old Wistar rats were decapitated under pentobarbitone-Na anaesthesia. A segment of lumbosacral (L 6 -S 2 ) spinal cord was dissected out and sectioned with a vibratome tissue slicer (Dosaka, DTK-1000) to yield several transverse slices 400 mm thick containing the SDCN region. The slices were preincubated in well-oxygenated incubation solution (see below for the composition) for 50 min at room temperature (22 ± 258C). Thereafter, slices were treated enzymatically in well-oxygenated incubation solution containing 1 mg pronase/6 ± 8 ml for 20 min at 318C followed by exposure to 1 mg thermolysin/6 ± 8 ml for another 15 min in the same condition. After the enzyme treatment, the slices were kept in enzyme-free incubation solution for 1 h. Then a portion of SDCN region was micropunched out with an electrolytically polished injection needle and transferred into a culture dish ®lled with standard external solution (see below). Neurones were mechanically dissociated by ®re-polished Pasteur pipettes with visual guidance under a phase contrast microscope (Nikon, TMS-1). Dissociated neurones adhered to the bottom of the dish within 20 min, allowing the electrophysiological studies to be conducted. The neurones that retained their original morphological features such as the dendritic processes were used for the experiments.
Solutions
The composition of incubation solution was (mM): NaCl 124, NaHCO 3 24, KCl 5, KH 2 PO 4 1.2, CaCl 2 2.4, MgSO 4 1.3 and glucose 10, aerated with 95% O 2 /5% CO 2 to a ®nal pH of 7.4. The normal external standard solution was (mM): NaCl 150, KCl 5, CaCl 2 2, MgCl 2 1, N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) 10 and glucose 10. The pH was adjusted to 7.4 with tris-hydroxymethyl aminomethane (Trisbase). The patch-pipette solution for nystatin perforated patch recording was (mM): CsCl 150 and HEPES 10. The pH was adjusted to 7.2 with Tris-base. A nystatin stock solution dissolved in acidi®ed methanol at a concentration of 10 mg ml 71 was prepared and stored at 7208C. The stock solution was added to the patch-pipette solution in a ®nal nystatin concentration of 200 mg ml 71 just before use. When the current-voltage (I-V) relationship for GABA-induced Cl 7 current was examined, 0.3 mM tetrodotoxin (TTX) and 10 mM CdCl 2 were added to the standard external solution.
Electrical measurement
Electrical measurements were carried out by using the nystatin perforated patch recording con®guration under the voltage-clamp condition at room temperature (22 ± 258C). Patch pipettes were pulled from glass capillaries with an outer diameter of 1.5 mm on a two-stage puller (Narishige, PB-7). The resistance between the recording electrode ®lled with pipette solution and the reference electrode was 4 ± 6 MO. Series resistance checked every 10 min was 10 ± 30 MO. The change of series resistance through recording was less than 10%. The current and voltage were measured with a patch-clamp ampli®er (Nihon Koden, CEZ-2300), ®ltered at 1 KHz (NF Electronic Instruments, FV-665), and monitored on both a storage oscilloscope (Iwatsu Electronic, 5100A) and a pen recorder (Nippondenki San-ei, RectiHoriz-8K21). Data were simultaneously stored on a video tape after digitization at a rate of 44 KHz (Nihon Koden, PCM 501 ESN). The membrane potential was held at 750 mV throughout the experiment, except when the I-V relationships were being examined. Measurements were started after the stabilization of the GABA response (15 ± 25 min after cell attachment).
Chemicals
Drugs used in the present experiments were: thermolysin, nystatin, 5-HT, GABA, bicuculline and muscimol from Sigma; (+)-8-OH-hydroxy-2-N, N-dipropylaminotetralin (8-OH-DPAT), a-methyl-5-HT, ketanserine, genistein, okadaic acid and chelerythrine from Research Biochemicals International; pronase and 1-oleoyl-2-acetyl-glycerol (OAG) from Calbiochem; (S)-5-¯uoro-8-hydroxy-2-(dipropylamino)-1,2,3,4-tetrahydronaphthalene hydrochloride ((S)-UH-301) was kindly provided by Yoshitomi Pharmaceutical Industries Ltd.; N-[2(methylamino)ethyl]-5-isoquinoline sulfonamide dihydrochloride (H-89) from Seikagaku corporation; 1,2-bis-(Oaminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA-AM) from Dojin; pertussis toxin (IAP) from Kaken Seiyaku and TTX from Sankyo. Stock solutions of (S)-UH-301, OAG, genistein and okadaic acid were prepared in dimethyl sulphoxide (DMSO) and diluted to ®nal concentrations in the external standard solution. The ®nal concentration of DMSO was always less than 0.01%, and it did not induce any ionic current and had no eect on GABA response at the concentrations used. Sodium pervanadate was prepared freshly by mixing 1 part 500 mM H 2 O 2 with 50 parts 10 mM sodium orthovanadate in saline; the solution was incubated for 15 min at room temperature to reduce H 2 O 2 (Catarsi & Drapeau, 1997) . Other drugs were either ®rst dissolved in distilled water and then diluted to the ®nal concentration in the external solution just before use or dissolved directly in the external solution. Drug solutions were applied by the`Y-tube' method (Xu et al., 1996) throughout the experiment. This system allows a complete exchange of external solution surrounding a neurone within 20 ms.
Statistical analysis
Michaelis-Menten equation using a least-squares ®tting was applied for evaluation of the half-maximal eective concentration (EC 50 ) of GABA in the GABA concentration-response relationships.
where I is current, I max is maximum response, n H is Hill coecient and C is the concentration of GABA and K d is the dissociation constant. Experimental values are shown as mean+s.e.mean. Student's t test was used when two groups were compared. P and n represent the value of signi®cance and number of cells, respectively. Figure  1Aa ). Muscimol (Mus, 10 76 M), a GABA A receptor agonist, also caused an inward current (I Mus ) with the current amplitude similar to that produced by 3610 76 M GABA. Baclofen, which is a GABA B receptor agonist, evoked no response at concentrations up to 10 73 M. These results suggested that the inward current produced by GABA is mediated by the GABA A receptor in the rat SDCN neurones. In the present experimental conditions, the pretreatment with 5-HT alone induced no noticeable current at concentrations up to 10 74 M in the rat SDCN neurones (Xu et al., 1996) . However, after the continuous application of 10 76 M 5-HT for 5 min, the simultaneous administration of GABA and 5-HT reversibly potentiated the I GABA in the majority of the neurones examined (82/100 cells), as shown in Figure 1Ab . I Mus was also enhanced by 5-HT (10 76 M) application (Figure 1Ac ). Figure 1B summarizes these experimental results. 5-HT caused a 1.38+0.09 (n=10) and 1.37+0.1 (n=5) times increase of I GABA and I Mus , respectively.
Results
Potentiation of GABA
Concentration-response curve and current-voltage relationship of I GABA
The amplitude of I GABA increased in a concentrationdependent manner (Figure 2a) (Figure 2a) , and that 5-HT does not alter the apparent anity of GABA to its receptor. Figure 2b shows the current-voltage (I-V) relationships for GABA with or without 10 76 M 5-HT. The reversal potentials (E GABA ) of GABA responses were 70.07+0.02 mV (n=5) in the control and 0.05+0.03 mV (n=4) with 10 76 M 5-HT. These E GABA values were close to the Cl 7 equilibrium potential (E Cl ) of 71.8 mV calculated by the Nernst equation, indicating that 5-HT increased the GABA-induced Cl 7 current without aecting other ionic channels. In addition, the potentiation induced by 5-HT showed no voltage-dependence. 
5-HT
To explore which 5-HT receptor subtypes mediate the potentiation of I GABA , the eects of several selective agonists and antagonists of 5-HT 1 and 5-HT 2 receptors were examined. 5-HT 1 agonist, 8-OH-DPAT (10 76 M), had no signi®cant eect on I GABA . However, a-methyl-5-HT (10 76 M), a 5-HT 2 selective agonist, mimicked the eect of 5-HT ( Figure 3A) . Furthermore, when ketanserine (3610 76 M), a 5-HT 2 selective antagonist was coadministered with 10 76 M 5-HT, it prevented the facilitation of I GABA . On the other hand, (S)-UH-301 (10 75 M), a 5-HT 1 selective antagonist, had no signi®cant eect on the potentiation of I GABA by 5-HT ( Figure 3B ). These results indicate that activation of the 5-HT 2 receptor is mainly responsible for the potentiation of I GABA by 5-HT.
Involvement of protein kinase C
Several laboratories have shown that second messenger regulated protein kinases modulate GABA A receptor function (for review, see Smart, 1997) . Activation of 5-HT 2 receptor stimulates phosphoinositide hydrolysis by activating phospholipase C (PLC) in neurones (Martin & Humphrey, 1994) . The phosphoinositide hydrolysis produces two second messengers, inositol-1,4,5-trisphosphate (IP 3 ) which results in Ca 2+ release from intracellular Ca 2+ pools, and diacylglycerol (DAG), an activator of protein kinase C (PKC). Since previous experiments have demonstrated that the enhancement of glycine response in the rat sacral dorsal commissural neurones by 5-HT is mediated by intracellular PKC (Xu et al., 1996) , we therefore tested whether a similar modulation of I GABA by PKC is conserved in the present preparation. 1-Oleoyl-2-acetylglycerol (OAG) (3610 76 M), a membrane-permeable DAG analogue, mimicked the 5-HT eect on I GABA . In the presence of OAG, 5-HT did not potentiate I GABA any more (Figure 4Aa , B). After neurones had been loaded with 3610 76 M chelerythrine, a membrane-permeable PKC inhibitor, application of 10 76 M 5-HT also failed to enhance I GABA (Figure 4Ab , B). Both OAG and chelerythrine themselves did not elicit any current in the present experimental conditions. The results suggest that 5-HT and PKC share a common pathway in facilitating I GABA in SDCN neurones.
To determine the role of intracellular Ca 2+ on the 5-HTinduced potentiation of I GABA , the eect of BAPTA-AM, a membrane-permeable Ca 2+ chelator, was examined. When the SDCN neurones were loaded with 3610 76 M BAPTA-AM for 2 h, the potentiation of I GABA by 5-HT (138.1+9.0%, n=6, P50.01) remained almost the same as that observed in the control neurones without BAPTA-AM treatment. In the presence of LiCl, which has been shown to increase intracellular IP 3 concentration by inhibiting 1-phosphatase (Xu et al., 1996) , 5-HT did not induce further facilitation of I GABA (95.4+4.6% of that before LiCl application, n=4, P40.05, Figure 4Ac , B).
Eects of H-89, genistein, okadaic acid and pervanadate on I GABA To examine the possible contributions of cyclic AMPdependent protein kinase A (PKA), protein tyrosine kinases (PTKs) and protein phosphatases to the 5-HT-induced increase of I GABA , SDCN neurones were pretreated with either H-89 (10 76 M), a membrane-permeant PKA inhibitor (Xu, 1997) , or genistein (5610 75 M), a membrane-permeant PTKs inhibitor (Wan et al., 1997) , or okadaic acid (2610 76 M), a membrane-permeant inhibitor of phosphatases 1, 2A and 2B (calcineurin) (Cheng & Wong, 1995) . The facilitatory eect of 5-HT on I GABA was not aected by these drugs ( Figure 5A) .
Recently, it has been shown that 5-hydroxytryptaminergic stimulation of PKC activates a tyrosine phosphatase activity which associated with channels in leech pressure-sensitive neurones (Catarsi & Drapeau, 1997) . Therefore, the possible contribution of dephosphorylation of the GABA A receptorCl 7 chanel complex by tyrosine phosphatase to 5-HT-induced potentiation of I GABA was examined. When the SDCN neurones were exposed to 10 74 M sodium pervanadate, a membrane-permeable form of vanadate which inhibits tyrosine a b phosphatase (Catarsi & Drapeau, 1997) , the 5-HT potentiation of I GABA remained almost the same as that observed in control neurones without vanadate treatment ( Figure 5A ). Thus, PKA, PTKs, protein phosphatases and tyrosine phosphatase are unlikely to be involved in mediating the 5-HT potentiation of I GABA in the SDCN neurones.
Properties of G-protein
To examine whether G-protein is involved in the 5-HT action on I GABA , the dissociated SDCN neurones were incubated in standard external solution with or without pertussis toxin (IAP) (300 ng ml 71 ) for 6 to 8 h at room temperature. To elucidate the eectiveness of IAP treatment, the disappearance of IAP-sensitive suppression of Ca 2+ channel current by 5-HT was con®rmed in the IAP-treated preparations (Xu et al., 1996) . In the control neurones without IAP treatment, 10 76 M 5-HT enhanced the I GABA by 137.3+7.3% (n=4; P50.01, Figure 5Ba, c) . Even in the IAP-treated neurones, in which 5-HT suppression of Ca 2+ channel current disappeared, the application of 10 76 M 5-HT caused almost an equal potentiation of I GABA by 138.3+7.9% (n=4; P50.01, Figure  5Bb , c). These results suggest that the IAP-insensitive Gprotein is coupled to the potentiation of I GABA by 5-HT.
Discussion
Cross-communication between 5-HT and GABA A receptors
Receptors that activate complex intracellular signal transduction cascades and produce changes in the levels of second messengers such as Ca 2+ , cyclic AMP, cyclic GMP, DAG, and IP 3 , are known to regulate the activity of numerous target enzymes, which in turn, could modulate the function of the GABA A receptors (for review, see Smart, 1997) . G-proteincoupled 5-HT receptors are one of the most important family of regulatory receptors in the central nervous system (CNS). Several studies suggest that GABA A and 5-HT receptors, and the neurotransmitters GABA and 5-HT, colocalize in some neuronal populations. Double immunostaining for 5-HT and glutamic acid decarboxylase, the enzyme responsible for the conversion of glutamic acid into GABA, is detected in the raphe nuclei of the rat medulla oblongata (Millhorn et al., 1987) . 5-HT aects the frequency of GABA A -receptordependent inhibitory postsynaptic currents in neurones from ventral tegmenta area and substantia nigra (Pessia et al., 1994) , modulates muscimol-induced inhibition of the activity of cerebellar Purkinje cells (Strahlendorf et al., 1991) , and facilitates GABAergic inputs to cat dorsal lateral geniculate relay cells (Funke & Eysel, 1995) . Moreover, 5-HT inhibits the GABA A receptor-mediated response in the rat suprachiasmatic neurones by stimulation of the 5-HT 7 receptor subtype (Kawahara et al., 1994) and the GABA A receptors in Xenopus oocytes coexpressing the 5-HT 2C receptor (Huidobro-Toro et al., 1996) . The present study has shown that 5-HT facilitates the GABA A receptor response in the rat SDCN neurones and that the 5-HT potentiation of I GABA is mediated by activation of the 5-HT 2 receptor. Given that SDCN is implicated in nociceptive transmission (Lu et al., 1995) and receives projections for the descending 5-hydroxytryptaminergic pathway (Xu et al., 1996) , the results provide a potential mechanism for the regulation of these spinal neurones by 5-hydroxytryptaminergic antinociceptive inputs. Furthermore, the present results together with the above observations extend the hypothesis that GABA and 5-HT could act as cotransmitters in some regions of the CNS and cross-communication between 5-HT and GABA receptors may be an important modulatory process of spinal nociceptive signals, such as pain.
Intracellular mechanisms of 5-HT potentiation of I GABA
A large number of studies have demonstrated that PKC inhibits GABA A receptor function (for review, see Smart, 1997) , and this eect appears to be attributable to phosphorylation of the b and g2 subunits on serine residues (Krishek et al., 1994) . However, on recombinant GABA A receptors, PKM (a constitutively activated form of PKC) enhances GABA responses; this eect is abolished by mutation of selected serine residues (Lin et al., 1996) . It is unclear whether the apparent dierential modulation of GABA A receptors by PKC is attributable to the use of dierent expression systems or due to the heterogeneity of the subunit combinations of the receptors in dierent preparations. Modulation of I GABA need not have arisen either in entirety or in part from the direct phosphorylation of receptor proteins. Therefore, a more substantive dierence is the dierent mechanisms after PKC activation that modulate such GABA responses, such as PKC itself, PKA (Sugita et al., 1997) and Ca 2+ /CaMKII (Browning & Dudek, 1992) , PTKs (Kawakami et al., 1995) and tyrosine phosphatase (Catarsi & Drapeau, 1997) , in dierent preparations. In the present SDCN neurones, mechanisms other than the interactions with PKA, Ca 2+ /CaMKII, PTKs, or tyrosine phosphatase might be involved in mediating the 5-HT potentiation of I GABA , since neither H-89, the PKA inhibitor, nor BAPTA AM, the Ca 2+ chelator, nor genistein, the PTKs inhibitor, nor pervanadate, the tyrosine phosphatase inhibitor aected the 5-HT potentiation of I GABA . Dephosphorylation of GABA A receptors by protein phosphatases (Chen & Wong, 1995) may also not be involved in this process, because okadaic acid, the protein phosphatase inhibitor, had no eect on 5-HT potentiation of I GABA .
The ®nding of Ca 2+ -dependent regulation of GABA A receptors has led to the speculation that cellular events causing an increase in neuronal Ca 2+ will suppress GABA A receptor function (Akaike et al., 1992) . In a recent study, Harris and colleagues (Huidobro-Toro et al., 1996) found that 5-HT 2C receptors inhibit GABA A receptors by a Ca 2+ -dependent, but phosphorylation-independent mechanism. One may expect that all 5-HT 2 receptor subtypes (i.e. 5-HT 2A ± 2C ) have the ability to produce inhibition of the GABA A response, given that all 5-HT 2 receptors seem to share the same signal transduction pathways, including mobilization of intracellular Ca 2+ (Martin & Humphrey, 1994) . However, in the present study, the manipulation of intracellular Ca 2+ and IP 3 concentrations did not aect the 5-HT potentiation of I GABA , indicating that neither Ca 2+ nor IP 3 are involved in 5-HTinduced potentiation of I GABA in the rat SDCN neurones. Thus, the cascade for signal transduction in the SDCN neurones would be that activation of the 5-HT 2 receptor leads to activation of a IAP-sensitive G protein, resulting in activation of PLC. Hydrolysis of inositol phospholipids by PLC results in the activation of DAG, which causes PKC activation that might directly phosphorylate the GABA A receptor on serine residues.
Functional implications
As mentioned before (see Introduction), activation of RVM neurones by electrical stimulation or glutamate microinjection depresses the activity of nociceptive neurones in the spinal dorsal horn, and produces behavioural antinociception (Basbaum et al., 1976; Jensen & Yaksh, 1989) . It has generally been assumed that inhibition of spinal nociception evoked by RVM stimulation is due to the activation of a spinally projecting cell population that releases 5-HT. However, a growing body of experimental evidence suggests that RVM is not a homogeneous population of 5-HT cells, and that multiple neurotransmitters are possibly involved when raphe-spinal neurones are activated (Antal et al., 1996) . Alternatively, it is quite likely that neurotransmitters other than 5-HT also participate in RVM-produced antinociception and are released following stimulation in addition to 5-HT. Indeed, the extensive 5-hydroxytryptaminergic and GABAergic innervation of the spinal dorsal horn by ®bres descending from RVM has been demonstrated recently and the spinal corelease of 5-HT and GABA, in some case probably together with glycine, is likely to be crucial in RVM-spinal synaptic transmission (Antal et al., 1996) . Furthermore, the ®nding of colocalization of GABA, glycine, and their receptors at the synapses in the rat spinal cord has led to the speculation that GABA and glycine could act as cotransmitters in the spinal cord (Todd et al., 1996) . Thus, the results presented in this paper and a previous paper by the same authors (Xu et al., 1996) have important functional implications concerning the descending control of spinal nociceptive signal processing. Although speculative, it is possible that volleys in RVM-spinal tract may evoke the release of 5-HT, GABA and/ or glycine from RVM terminals, and they may then act as cotransmitters to inhibit nociceptive spinal interneurones and supraspinally projecting cells through GABA A and/or glycine receptors at a site postsynaptic to terminals of primary aerent ®bres, resulting in both analgesia and attenuation of pain behaviour (Sorkin et al., 1993; Lin et al., 1994) . If the descending antinociceptive system in man operates similarly, the simultaneous activation of descending RVM ®bres and the potentiation of GABAergic and glycinergic neurotransmission within spinal dorsal horn may turn out to be a useful alternative to addictive opioid analgesics. Thus, a more exhaustive understanding of GABAergic and glycinergic mechanisms in pain perception may lead to the development of new nonopioid, non-addictive analgesics.
